Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia
Active, not recruitingOBSERVATIONAL
Enrollment
918
Participants
Timeline
Start Date
January 31, 2020
Primary Completion Date
July 15, 2028
Study Completion Date
July 15, 2028
Conditions
Dengue Fever
Trial Locations (1)
Unknown
Investigational site Colombia, Colombia
All Listed Sponsors
lead
Sanofi Pasteur, a Sanofi Company
INDUSTRY
NCT04113330 - Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia | Biotech Hunter | Biotech Hunter